Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD in Japanese Subjects With Type 2 Diabetes
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 11 Dec 2017
At a glance
- Drugs Semaglutide (Primary) ; Dulaglutide
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Registrational
- Acronyms PIONEER 10
- Sponsors Novo Nordisk
- 07 Dec 2017 Planned End Date changed from 2 Aug 2018 to 16 Jul 2018.
- 07 Dec 2017 Planned primary completion date changed from 28 Jun 2018 to 16 Jul 2018.
- 21 Nov 2017 According to a Novo Nordisk media release, the trial is expected to be completed in 2018.